NCT02213094View on ClinicalTrials.gov

Phase I Study of Nicotinamide for Early Onset Preeclampsia

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

December 3, 2015

Study Completion Date

December 3, 2015

Conditions
Pregnancy Induced HypertensionSuperimposed PreeclampsiaHypertension
Interventions
DRUG

Nicotinamide 500 mg

Nicotinamide 500 mg taken by mouth each morning

DRUG

Nicotinamide 1000 mg

Nicotinamide 1000 mg taken by mouth each morning

Trial Locations (1)

27599-7516

University of North Carolina Women's Hospital, Chapel Hill

All Listed Sponsors
collaborator

North Carolina Translational and Clinical Sciences Institute

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT02213094 - Phase I Study of Nicotinamide for Early Onset Preeclampsia | Biotech Hunter | Biotech Hunter